BI-1622 is an orally active, potent and highly selective HER2 (ERBB2) inhibitor, with an IC50 of 7 nM. BI-1622 shows greater than 25-fold selectivity over EGFR. BI-1622 shows high antitumor efficacy in vivo in xenograft mouse tumor models with engineered H2170 and PC9 cells and had a favorable agent metabolism and pharmacokinetics profile[1].
Molecular Weight:
508.53
Purity:
98.97
CAS Number:
[2681392-19-6]
Formula:
C26H24N10O2
Target:
Btk,CDK,EGFR,Itk,JAK,PI4K,Raf
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted